Progress review: the relationship between dose of aspirin, side-effects and antithrombotic effectiveness.
D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D001792:Blood Platelets / Q000378:metabolism; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D011464:Epoprostenol / Q000096:biosynthesis; D005260:Female; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005753:Gastric Mucosa / Q000187:drug effects; D006801:Humans; D008297:Male; D013928:Thromboxane A2 / Q000096:biosynthesis
D005343:Fibrinolytic Agents; D013928:Thromboxane A2; D011464:Epoprostenol; D001241:Aspirin